Primary outcomes: safety and feasibility
ADVERSE EVENTS, ADVERSE EVENT
The study accumulated 168 participant-months of DBS implant experience and 72 months of DN stimulation experience, with no device failures and no study-related, serious adverse events throughout the trial. A total of 51 adverse events were recorded during the trial, including 21 deemed related to study participation. Table Incidence of adverse events during the trialAE, adverse event; SAE, serious adverse event; rehab, rehabilitation.